TrialPath
← Back to searchRecruiting

ICU-VR Prior to ICU Admission

NCT06642636 · Erasmus Medical Center
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Intensive Care Unit-specific Virtual Reality As Preparation for ICU Admission in Lung Transplant Patients
About this study
Rationale: A substantial proportion of the Intensive Care Unit (ICU) survivors develop psychological impairments due to their ICU admission. Several interventions to mitigate these impairments have been explored but lack a proper effect. Intensive Care Unit-specific Virtual Reality has proven to be potentially effective in treating PTSD and depression-related sequelae in ICU-survivors. Objective: To evaluate the contribution in terms of information provision and patients' perspectives of ICU-VR to prepare lung transplant patients for their future ICU admission Study design: A monocentre randomized controlled study Study population: Lung transplant patients who are on the waiting list and understand the Dutch language. Due to the criteria for lung transplantation, these are 18-71 years of age. Participants need to have signed the informed consent formular. Intervention: The ICU-VR intervention is designed by an interdisciplinary team of intensivists, ICU nurses, a psychiatrist, a psychologist, and a former ICU patient, to expose patients to the ICU environment while offering treatment- and department-related information. During the 12-minute lasting intervention, patients experience different facets of ICU treatment and receive information on the ICU environment, treatment, and workflow. The intervention group will receive this treatment during the appointment with the lung transplantation nurse. The control group will receive the regular hospital preparation care. Primary endpoints: The primary endpoint will be the difference in information provision of the ICU care of lung transplant patients on the waiting list.
Eligibility criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Be on the waiting list for lung transplantation * Age 18-71 years (maximum age for lung transplantation is 71 years) * Understand the Dutch language * Signed informed consent Exclusion Criteria: While patients on the waiting list for lung transplantation are intensively monitored and only placed on the waiting list under strict conditions, no additional exclusion criteria above these are identified to exclude specific patients.
Study design
Enrollment target: 40 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2025-02-28
Estimated completion: 2025-12-31
Last updated: 2025-03-04
Interventions
Device: Intensive Care Unit-specific Virtual Reality
Primary outcomes
  • Percieved quality of information provision (Participants will be followed from inclusion until two weeks after ICU admission, when they complete the last questionnaires.)
Sponsor
Denzel Drop · other
Contacts & investigators
ContactDenzel LQ Drop, MD · contact · d.drop@erasmusmc.nl · 0031629659221
All locations (1)
Erasmus Medical CenterRecruiting
Rotterdam, South Holland, Netherlands
ICU-VR Prior to ICU Admission · TrialPath